[{"from": "human", "value": "What can you tell me about this molecule? [C][C][=C][C][=C][Branch2][Ring1][N][C][=C][C][Ring1][=Branch1][=C][Branch2][Ring1][C][C][=Branch1][Ring2][=N][Ring1][#Branch2][C][=Branch1][C][=O][N][C][C][=Branch1][C][=O][O][O][O][C][=C][C][=C][C][=C][Ring1][=Branch1]"}, {"from": "gpt", "value": "The molecule is a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor used to treat anemia associated with chronic kidney disease. It works by reducing the breakdown of the hypoxia-inducible factor (HIF), which is a transcription factor that stimulates red blood cell production in response to low oxygen levels. Roxadustat was first approved by the European Commission in August 2021."}]